The expressions of CEACAM1 and TGF-β were correlated with clinical differentiation level, lymph node metastasis, and stage (P < 0.05), but were not correlated with gender, age, and tumor diameter (P > 0.05). Here, CEACAM1 is linked to neoplasm.